Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (771-780 of 777) with videos related to

Pageof 78
Sort By:
You have reached the last page of results.This site can display upto 777 results.
Gut|May 18, 2021
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisFerenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, et al.
Gut|August 3, 2018
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosisPavel Strnad, Stephan Buch, Karim Hamesch, et al.
Hepatology (Baltimore, Md.)|December 7, 2024
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapyBernhard Scheiner, Beodeul Kang, Lorenz Balcar, et al.
Immunity|June 17, 2023
Sublethal necroptosis signaling promotes inflammation and liver cancerMihael Vucur, Ahmed Ghallab, Anne T Schneider, et al.
The Lancet. Gastroenterology & Hepatology|June 8, 2023
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysisFerenc E Mózes, Jenny A Lee, Yasaman Vali, et al.
Gastroenterology|March 10, 2017
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing CholangitisTobias J Weismüller, Palak J Trivedi, Annika Bergquist, et al.
Nature|December 5, 2022
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2Teresa Brevini, Mailis Maes, Gwilym J Webb, et al.
Pageof 78

Showing results (771-780 of 777) with videos related to

Sort By:
Pageof 78
You have reached the last page of results.This site can display upto 777 results.
Gut|May 18, 2021
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisFerenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, et al.
Gut|August 3, 2018
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosisPavel Strnad, Stephan Buch, Karim Hamesch, et al.
Hepatology (Baltimore, Md.)|December 7, 2024
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapyBernhard Scheiner, Beodeul Kang, Lorenz Balcar, et al.
Immunity|June 17, 2023
Sublethal necroptosis signaling promotes inflammation and liver cancerMihael Vucur, Ahmed Ghallab, Anne T Schneider, et al.
The Lancet. Gastroenterology & Hepatology|June 8, 2023
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysisFerenc E Mózes, Jenny A Lee, Yasaman Vali, et al.
Gastroenterology|March 10, 2017
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing CholangitisTobias J Weismüller, Palak J Trivedi, Annika Bergquist, et al.
Nature|December 5, 2022
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2Teresa Brevini, Mailis Maes, Gwilym J Webb, et al.
Pageof 78